Generics

Meitheal appointed Keith Robinson as chief medical officer; Lonnie Brent was appointed senior vice president of medical affairs.

Aurobindo Pharma USA will acquire Lannett from Lannett Seller Holdco for $250 million on a cash-free, debt-free basis.

The acquisition would reinforce in-house biosimilar development and manufacturing capabilities, while creating additional strategic flexibility.

Ibrutinib is a kinase inhibitor indicated for the treatment of adult patients with chronic lymphocytic leukemia/small lymphocytic lymphoma with 17p deletion, and Waldenstrom's macroglobulinemia.

Generic Entresto is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients.

Prucalopride tablets are indicated for the treatment of chronic idiopathic constipation in adults.

Liraglutide injection single-patient-use prefilled pens and glucagon for injection vials will be manufactured at Lupin’s injectable facility at Nagpur, India.

Governor Reynolds met with leaders from Upsher-Smith and Bora Group to discuss pharmaceutical innovation and exploring opportunities for regional collaboration.